Table of Contents
<< Previous Issue | Sep 2002 (Vol: 2002, Issue: 28) | Next Issue >> |
- Section: Company Profile
-
Grupo Ferrer Internacional SA
- Section: Distribution & Marketing
-
Oryx Pharmaceuticals to Market CNS Drugs in Canada
-
Key Oncologics to Market Eligard™ in South Africa
- Section: General
-
Big Pharma Mergers
-
Testing for Genetic Variation
-
Therapy Focus: Dyslipidemia and the Statins
- Section: Licensing
-
Diacrin Licenses Transplantation Technology to Terumo
-
Crucell and NatImmune Sign Licensing Agreement
-
Amsterdam Molecular Therapeutics Licenses Rights to IL-10
-
Adolor to License Key Technology from Eli Lilly
- Section: Mergers & Acquisitions
-
Novartis to Acquire Slovenian Generics Company
-
DSM to Acquire Roche’s Vitamins and Fine Chemicals Division
- Section: Research & Development
-
Dendreon and Genentech to Collaborate on Trp-p8 Gene Platform
-
IDEC and Caprion Pharmaceuticals to Search for Novel Cancer Antigen Targets